2021
DOI: 10.3390/mps4010018
|View full text |Cite
|
Sign up to set email alerts
|

Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration

Abstract: The Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) causes Coronavirus disease-2019 (COVID-19), which is an ongoing pandemic that has significantly affected the health, economy, and socio-economic status of individuals worldwide. Laboratory research using in vitro, ex vivo and in vivo models has been accelerated to understand the pathogenesis of SARS-CoV-2 infection. However, such experimental research involving SARS-CoV-2 is restricted to biocontainment/safety level-3 (BSL-3) settings, due to the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 19 publications
0
12
0
Order By: Relevance
“…Then the wells were replenished with 2 mL of DMEM + FBS. At 24 h post-infection, the cell culture supernatants were removed and the cells were fixed with 4% paraformaldehyde (Cat# 19943-k2, Thermo Scientific, USA) as described previously 71 .…”
Section: Methodsmentioning
confidence: 99%
“…Then the wells were replenished with 2 mL of DMEM + FBS. At 24 h post-infection, the cell culture supernatants were removed and the cells were fixed with 4% paraformaldehyde (Cat# 19943-k2, Thermo Scientific, USA) as described previously 71 .…”
Section: Methodsmentioning
confidence: 99%
“…8 SARS-CoV-2 can be inactivated in different tissue and fluid samples using several methods, including ultraviolet irradiation, formalin fixation, and heat inactivation. 18 , 19 , 24 , 36 Federal regulations require that institutions have internally validated inactivation data for all work with Select Agents, 7 where each proposed inactivation method must be validated in each specific tissue or fluid specimen that will potentially be removed from the BSL3 facility and approved by an internal regulatory group, usually the IBC. 25 Published and well-established protocols for inactivating nonselect BSL3 agents, such as SARS-CoV-2 and M. tuberculosis , can be used to remove samples from the BSL3 facility, but institutions may still require their high-containment laboratories to perform internal inactivation validation studies for certain tissues or when using specific pathogen strains.…”
Section: High-containment Laboratoriesmentioning
confidence: 99%
“…Then the wells were replenished with 2 mL of DMEM + FBS. At 24 hours post-infection, the cell culture supernatants were removed and the cells were xed with 4% paraformaldehyde (Cat# 19943-k2, Thermo Scienti c, USA) as described previously 69 .…”
Section: Vero E6 Cell Culture and Sars-cov-2 Infectionmentioning
confidence: 99%